Keyphrases
Gram-negative Bacteremia
100%
Randomized Controlled Trial
54%
Short Course
50%
Antibiotic Therapy
50%
Confidence Interval
49%
All-cause Mortality
45%
Antibiotic Duration
29%
Blood Culture
27%
Liver Disease
27%
Readmission
25%
Multicenter Cohort Study
25%
Blood Neutrophil-to-lymphocyte Ratio
25%
90-day Mortality
25%
Neutrophil-lymphocyte Ratio
25%
GNB5
25%
Early Switch
25%
Convalescent Plasma
25%
Liver-related Mortality
25%
Antibiotic Treatment
25%
Infected Individual
25%
Long-course
25%
CD4+ T Lymphocytes
25%
Oral Antibiotics
25%
COVID-19 Pneumonia
25%
Randomized Placebo-controlled Trial
25%
Community-acquired Pneumonia
25%
Intravenous to Oral Switch
25%
Target Trial
25%
HIV-HCV
25%
Adjusted Hazard Ratio
20%
Risk Ratio
19%
Risk Difference
19%
Odds Ratio
17%
Length of Hospital Stay
16%
Denmark
14%
Intravenous Treatment
14%
Intravenous Antibiotic Treatment
14%
Intention-to-treat
13%
Clinical Status
12%
Clinical Progression
12%
Mortality Prediction
12%
Per-protocol Analysis
11%
Noninferiority Margin
10%
Optimal Duration
10%
Lymphocyte Subsets
10%
CD4 Cells
10%
Mortality Risk
10%
CD4%
10%
Short-term Treatment
8%
Treatment Duration
8%
Medicine and Dentistry
Gram Negative Sepsis
100%
Antibiotic Therapy
92%
Randomized Controlled Trial
54%
Antibiotics
36%
All Cause Mortality
35%
Cohort Analysis
32%
Blood Culture
27%
COVID-19
25%
Community-Acquired Pneumonia
25%
Neutrophil
25%
Lymphocyte
25%
Placebo
25%
Attributable Risk
22%
Treatment Duration
20%
Infection
20%
Intention-to-Treat Analysis
19%
Arm
16%
Odds Ratio
14%
Adverse Event
8%
Pathogen
8%
Urinary Tract Infection
6%
Escherichia coli
6%
Logistic Regression Analysis
5%
Convalescence
5%
Infusion
5%
Immunotherapy
5%
Group Therapy
5%
